Research Use Only
5-Amino-1MQ
Price range: $45.00 through $75.00
Strength: 10MG / 20MG / 50MG
| # Purchased | Discounted Price |
|---|---|
| 5 - 9 | $42.75 |
| 10 + | $40.50 |
- Product Reference
- 5AM-PW
- Documentation
- Find This Product’s Reports ↗
For laboratory research use only. Not for human consumption. No dosing or administration guidance is provided.
About 5-Amino-1MQ
Material5-Amino-1MQ
Available OptionsStrength: 10MG / 20MG / 50MG
5-Amino-1MQ is a small molecule that blocks the enzyme Nicotinamide N-methyltransferase (NNMT). This enzyme changes the NAD+ salvage pathway by adding a methyl group to nicotinamide, a form of vitamin B3. When NNMT interferes, the enzyme NAMPT cannot turn nicotinamide into NMN, which is needed to create NAD+. Because NAD+ drives cell energy, this shift directly affects how the body uses fuel.
Researchers study this compound to better understand metabolism. It is a small-molecule NNMT inhibitor studied in in-vitro and animal models of adipocyte metabolism. In laboratory models, NNMT inhibition is studied in relation to NAD+ metabolism.
Scientists store 5-Amino-1MQ in a cool, dry place away from light. They follow lab safety rules whenever they handle it. It is not a food, drug, or cosmetic, and no person or animal should consume it.
This compound comes in powder form with purity above 98.5%. Researchers use it only for lab work, including in-vitro and early-stage studies. With it, they gain a reliable tool to explore metabolism, NNMT activity, and energy balance.
Product. Strength. Lot.
Search the original archive for 5-Amino-1MQ. Verify the complete lot number on your label against the report.
Supporting Images 3 files
Original images attached to this product. For lot, strength and report dates, use the searchable archive above and verify the document itself.
- Catalog Name
- 5-Amino-1MQ
- Product Reference
- 5AM-PW
- Intended Use
- Laboratory research only
| Strength | 10MG, 20MG, 50MG |
|---|
Shipping and returns
Need a product or lot record?
Include the product name and lot number when contacting support.
Contact support
Watowich, P.A., et al. (2022). "Nicotinamide N-methyltransferase inhibition for treatment of age-associated functional decline in mice."
Kraus, D., et al. (2014). "Nicotinamide N-methyltransferase an emerging player in metabolic diseases."
